InvestorsHub Logo
Followers 66
Posts 7341
Boards Moderated 0
Alias Born 04/08/2012

Re: toofun post# 117898

Monday, 07/28/2014 4:30:16 PM

Monday, July 28, 2014 4:30:16 PM

Post# of 400568
How is it baseless? Let's face it Isradapine will be good for the revenue # but I think I can speak for everyone in saying that we're not here for an extra 200k a quarter in revenue. Until some investors/traders get the news they're looking for, then they will play the range on the charts accordingly. That news is most likely more trial results/big partner news/NDA filing late this year.

For the past 4 months the range has been low .30's to high .40's. How's that for rationalization?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News